Differential uptake and processing of a Haemophilus influenzae P5-derived immunogen by chinchilla dendritic cells

Infection and Immunity

Volumn 76, Issue 3, 2008, Pages 967-977

  Novotny, Laura A ^a   Partida Sánchez, Santiago ^a   Munson Jr , Robert S ^a   Bakaletz, Lauren O ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; BIOLOGICAL MARKER; CD3 ANTIGEN; PROTEIN LB1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; HAEMOPHILUS VACCINE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD3+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL STRUCTURE; CHINCHILLA; CONTROLLED STUDY; DENDRITIC CELL; HAEMOPHILUS INFLUENZAE; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; OTITIS MEDIA; PHENOTYPE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UPREGULATION; ANIMAL; CELL PROLIFERATION; CHEMISTRY; CHEMOTAXIS; CYTOLOGY; GENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD80; BACTERIAL OUTER MEMBRANE PROTEINS; CELL PROLIFERATION; CHEMOTAXIS; CHINCHILLA; DENDRITIC CELLS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; OTITIS MEDIA; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 40749156281     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01395-07     Document Type: Article

References (74)

1. Adams, L., L. A. Novotny, S. R. Hill, S. Sethi, T. F. Murphy, and L. O. Bakaletz. 2007. Epitope-mapping the immune response of children with otitis media and adults with chronic obstructive pulmonary disease to the PilA protein of the nontypeable Haemophilus influenzae type IV pilus, abstr. D-58, p. 253. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, DC.
2. Adams, L., L. A. Novotny, S. Sethi, T. F. Murphy, and L. O. Bakaletz. 2007. Eptiope-mapping the immune response of children with otitis media and adults with chronic obstructive pulmonary disease to the PilA protein of nontypeable Haemophilus influenzae type IV pilus, p. 130. Abstr. Ninth Int. Symp. Recent Adv. Otitis Media.
3. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
4. Avadhanula, V., C. A. Rodriguez, G. C. Ulett, L. O. Bakaletz, and E. E. Adderson. 2006. Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. Infect. Immun. 74:830-838.
5. Bakaletz, L. O., B. D. Baker, J. A. Jurcisek, A. Harrison, L. A. Novotny, J. E. Bookwalter, R. Mungur, and R. S. Munson, Jr. 2005. Demonstration of type IV pilus expression and a twitching phenotype by Haemophilus influenzae. Infect. Immun. 73:1635-1643.
6. Bakaletz, L. O., and K. A. Holmes. 1997. Evidence for transudation of specific antibody into the middle ears of parenterally immunized chinchillas after an upper respiratory tract infection with adenovirus. Clin. Diagn. Lab. Immunol. 4:223-225.
7. Bakaletz, L. O., B. J. Kennedy, L. A. Novotny, G. Duquesne, J. Cohen, and Y. Lobet. 1999. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect. Immun. 67:2746-2762.
8. Bakaletz, L. O., E. R. Leake, J. M. Billy, and P. T. Kaumaya. 1997. Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla. Vaccine 15:955-961.
9. Bakaletz, L. O., B. M. Tallan, T. Hoepf, T. F. DeMaria, H. G. Birck, and D. J. Lim. 1988. Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect. Immun. 56:331-335.
10. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
11. Bookwalter, J. E., J. A. Jurcisek, S. D. Gray-Owen, S. Fernandez, G. McGillivary, and L. O. Bakaletz. 2008. A carcinoembryonic antigen-related cell adhesion molecule 1 homologue plays a pivotal role in nontypeable Haemophilus influenzae colonization of the chinchilla nasopharynx via the outer membrane protein P5-homologous adhesin. Infect. Immun. 76:48-55.
12. Bouchet, V., D. W. Hood, J. Li, J. R. Brisson, G. A. Randle, A. Martin, Z. Li, R. Goldstein, E. K. Schweda, S. I. Pelton, J. C. Richards, and E. R. Moxon. 2003. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. USA 100:8898-8903.
13. Cripps, A. W., and D. C. Otczyk. 2006. Prospects for a vaccine against otitis media. Exp. Rev. Vaccines 5:517-534.
14. Crowe, S. R., S. C. Miller, R. M. Shenyo, and D. L. Woodland. 2005. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. J. Immunol. 174:696-701.
15. Daines, D. A., M. Bothwell, J. Furrer, W. Unrath, K. Nelson, J. Jarisch, N. Melrose, L. Greiner, M. Apicella, and A. L. Smith. 2005. Haemophilus influenzae luxS mutants form a biofilm and have increased virulence. Microb. Pathog. 39:87-96.
16. Del Giudice, G. 2003. Vaccination strategies. An overview Vaccine 21(Suppl. 2):S83-S88.
17. Eldika, N., and S. Sethi. 2006. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 12:118-124.
18. Figueira, M. A., S. Ram, R. Goldstein, D. W. Hood, E. R. Moxon, and S. I. Pelton. 2007. Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect. Immun. 75:325-333.
19. Giebink, G. S. 1999. Otitis media: the chinchilla model. Microb. Drug Resist. 5:57-72.
20. Giebink, G. S., M. Koskela, P. P. Vella, M. Harris, and C. T. Le. 1993. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media. J. Infect. Dis. 167:347-355.
21. Giebink, G. S., Y. Kurono, L. O. Bakaletz, J. M. Kyd, S. J. Barenkamp, T. F. Murphy, B. Green, P. L. Ogra, X. X. Gu, J. A. Patel, T. Heikkinen, S. I. Pelton, M. Hotomi, and P. Karma. 2005. Recent advances in otitis media. 6. Vaccine. Ann. Otol. Rhinol. Laryngol. Suppl. 194:86-103.
22. Giebink, G. S., J. D. Meier, M. K. Quartey, C. L. Liebeler, and C. T. Le. 1996. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. J. Infect. Dis. 173:119-127.
23. Gitiban, N., J. A. Jurcisek, R. H. Harris, S. E. Mertz, R. K. Durbin, L. O. Bakaletz, and J. E. Durbin. 2005. Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus. J. Virol. 79:6035-6042.
24. Haase, C., M. Ejrnaes, A. E. Juedes, T. Wolfe, H. Markholst, and M. G. von Herrath. 2005. Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood 106:4225-4233.
25. Heritage, P. L., B. J. Underdown, A. L. Arsenault, D. P. Snider, and M. R. McDermott. 1997. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am. J. Respir. Crit. Care Med. 156:1256-1262.
26. Hill, D. J., M. A. Toleman, D. J. Evans, S. Villullas, L. Van Alphen, and M. Virji. 2001. The variable P5 proteins of typeable and non-typeable Haemophilus influenzae target human CEACAM1. Mol. Microbiol. 39:850-862.
27. Hill, S. R., L. A. Novotny, and L. O. Bakaletz. 2005. Characterization of the immune response induced by a parenteral prime-mucosal boost immunization strategy vs. a mucosal priming and boosting regimen using the vaccine candidate LB1 against nontypeable Haemophilus influenzae-induced otitis media, p. 148. Abstr. Fifth Extraordinary Int. Symp. Recent Adv. Otitis Media.
28. Hill, S. R., L. A. Novotny, and L. O. Bakaletz. 2005. Characterization of the protective response induced by a mucosal immunization strategy vs. one of parenteral priming and mucosal boosting using an adhesin-based vaccine candidate against otitis media caused by nontypeable Haemophilus influenzae, abstr. D-099, p. 214. Abstr. 105th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
29. Hong, W., K. Mason, J. Jurcisek, L. Novotny, L. O. Bakaletz, and W. E. Swords. 2007. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect. Immun. 75:958-965.
30. Hong, W., B. Pang, S. West-Barnette, and W. E. Swords. 2007. Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J. Bacteriol. 189:8300-8307.
31. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
32. Jeannin, P., B. Bottazzi, M. Sironi, A. Doni, M. Rusnati, M. Presta, V. Maina, G. Magistrelli, J. F. Haeuw, G. Hoeffel, N. Thieblemont, N. Corvaia, C. Garlanda, Y. Delneste, and A. Mantovani. 2005. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551-560.
33. Jeannin, P., G. Magistrelli, L. Goetsch, J. F. Haeuw, N. Thieblemont, J. Y. Bonnefoy, and Y. Delneste. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells - impact on vaccine strategies. Vaccine 20(Suppl. 4):A23-A27.
34. Jeannin, P., T. Renno, L. Goetsch, I. Miconnet, J. P. Aubry, Y. Delneste, N. Herbault, T. Baussant, G. Magistrelli, C. Soulas, P. Romero, J. C. Cerottini, and J. Y. Bonnefoy. 2000. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1:502-509.
35. Jiang, Z., N. Nagata, E. Molina, L. O. Bakaletz, H. Hawkins, and J. A. Patel. 1999. Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect. Immun. 67:187-192.
36. Jurcisek, J. A., and L. O. Bakaletz. 2007. Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein. J. Bacteriol. 189:3868-3875.
37. Jurcisek, J. A., J. E. Durbin, D. F. Kusewitt, and L. O. Bakaletz. 2003. Anatomy of the nasal cavity in the chinchilla. Cells Tissues Organs 174:136-152.
38. Kanegasaki, S., Y. Nomura, N. Nitta, S. Akiyama, T. Tamatani, Y. Goshoh, T. Yoshida, T. Sato, and Y. Kikuchi. 2003. A novel optical assay system for the quantitative measurement of chemotaxis. J. Immunol. Methods 282:1-11.
39. Kennedy, B. J., L. A. Novotny, J. A. Jurcisek, Y. Lobet, and L. O. Bakaletz. 2000. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect. Immun. 68:2756-2765.
40. Kerschner, J. E., T. K. Meyer, A. Burrows, G. Ehrlich, and J. C. Post. 2006. Mucin gene cDNA sequence characterization in chinchilla middle ear epithelium. Int. J. Pediatr. Otorhinolaryngol. 70:1449-1456.
41. Kyd, J. M., and A. W. Cripps. 1998. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model. Infect. Immun. 66:2272-2278.
42. Kyd, J. M., A. W. Cripps, L. A. Novotny, and L. O. Bakaletz. 2003. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect. Immun. 71:4691-4699.
43. Lee, J. S., J. C. Lee, C. M. Lee, I. D. Jung, Y. I. Jeong, E. Y. Seong, H. Y. Chung, and Y. M. Park. 2007. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem. Pharmacol. 74:86-97.
44. Legge, K. L., and T. J. Braciale. 2003. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 18:265-277.
45. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
46. Mason, K. M., R. S. Munson, Jr., and L. O. Bakaletz. 2005. A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect. Immun. 73:599-608.
47. Miyamoto, N., and L. O. Bakaletz. 1996. Selective adherence of non-typeable Haemophilus influenzae (NTHi) to mucus or epithelial cells in the chinchilla Eustachian tube and middle ear. Microb. Pathog. 21:343-356.
48. Morelli, A., A. Larregina, I. Chuluyan, E. Kolkowski, and L. Fainboim. 1996. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology 89:126-134.
49. Morton, D. J., L. O. Bakaletz, J. A. Jurcisek, T. M. VanWagoner, T. W. Seale, P. W. Whitby, and T. L. Stull. 2004. Reduced severity of middle ear infection caused by nontypeable Haemophilus influenzae lacking the hemoglobin/hemoglobin-haptoglobin binding proteins (Hgp) in a chinchilla model of otitis media. Microb. Pathog. 36:25-33.
50. Murphy, T. F., and M. A. Apicella. 1987. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev. Infect. Dis. 9:1-15.
51. Murphy, T. F., L. O. Bakaletz, J. M. Kyd, B. Watson, and D. L. Klein. 2005. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23:2696-2702.
52. Nitta, N., T. Tsuchiya, A. Yamauchi, T. Tamatani, and S. Kanegasaki. 2007. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device - TAXIScan. J. Immunol. Methods 320:155-163.
53. Novotny, L. A., and L. O. Bakaletz. 2003. Intranasal immunization with a nontypeable Haemophilus influenzae adhesin-based vaccine candidate elicits a protetive immune response in a chinchilla model of otitis media, abstr. D-178, p. 234. Abstr. 103rd Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
54. Novotny, L. A., K. M. Mason, and L. O. Bakaletz. 2005. Development of a chinchilla model to allow direct, continuous, biophotonic imaging of bioluminescent nontypeable Haemophilus influenzae during experimental otitis media. Infect. Immun. 73:609-611.
55. Palucka, K., and J. Banchereau. 1999. Dendritic cells: a link between innate and adaptive immunity. J. Clin. Immunol. 19:12-25.
56. Poolman, J. T., L. Bakaletz, A. Cripps, P. A. Denoel, A. Forsgren, J. Kyd, and Y. Lobet. 2000. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19(Suppl. 1):S108-S115.
57. Reddy, M. S., J. M. Bernstein, T. F. Murphy, and H. S. Faden. 1996. Binding between outer membrane proteins of nontypeable Haemophilus influenzae and human nasopharyngeal mucin. Infect. Immun. 64:1477-1479.
58. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
59. Romani, N., G. Ratzinger, K. Pfaller, W. Salvenmoser, H. Stossel, F. Koch, and P. Stoitzner. 2001. Migration of dendritic cells into lymphatics - the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207:237-270.
60. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
61. Salucci, V., A. M. Lena, G. Ciliberto, E. Scarselli, and N. La Monica. 2005. Adenovirus transduction and culture conditions affect the immunogenicity of murine dendritic cells. Scand. J. Immunol. 62:206-217.
62. Sato, K., C. L. Liebeler, M. K. Quartey, C. T. Le, and G. S. Giebink. 1999. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect. Immun. 67:1943-1946.
63. Sato, K., M. K. Quartey, C. L. Liebeler, C. T. Le, and G. S. Giebink. 1996. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model. Infect. Immun. 64:1140-1145.
64. Sirakova, T., P. E. Kolattukudy, D. Murwin, J. Billy, E. Leake, D. Lim, T. DeMaria, and L. Bakaletz. 1994. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect. Immun. 62:2002-2020.
65. Spit, B. J., E. G. Hendriksen, J. P. Bruijntjes, and C. F. Kuper. 1989. Nasal lymphoid tissue in the rat. Cell Tissue Res. 255:193-198.
66. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
67. Steinman, R. M., D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, K. Mahnke, T. Iyoda, J. Ravetch, M. Dhodapkar, K. Inaba, and M. Nussenzweig. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987:15-25.
68. Sun, J., J. Chen, Z. Cheng, J. B. Robbins, J. F. Battey, and X. X. Gu. 2000. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine 18:1264-1272.
69. Suzuki, K., and L. O. Bakaletz. 1994. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 62:1710-1718.
70. Talmor, M., A. Mirza, S. Turley, I. Mellman, L. A. Hoffman, and R. M. Steinman. 1998. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur. J. Immunol. 28:811-817.
71. Torres, A. G., Y. Li, C. B. Tutt, L. Xin, T. Eaves-Pyles, and L. Soong. 2006. Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. Infect. Immun. 74:2676-2685.
72. Visweswaraiah, A., L. A. Novotny, E. J. Hjemdahl-Monsen, L. O. Bakaletz, and Y. Thanavala. 2002. Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention. Vaccine 20:3209-3220.
73. Wilson, H. L., and H. C. O'Neill. 2003. Murine dendritic cell development: difficulties associated with subset analysis. Immunol. Cell Biol. 81:239-246.
74. Wu, H. Y., H. H. Nguyen, and M. W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J. Immunol. 46:506-513.